Procedures for Determining an Acceptable Daily Exposure (ADE) under Risk-MaPP: Approaches for Developing and Documenting Acceptable Limits for Product Cross-Contamination Purposes (pdf)

Assessing Risk and Controlling Exposure to Potent Compounds During Pharmaceutical Packaging (pdf)

Applying Health-Based Risk Assessments to Worker and Product Safety for Potent Pharmaceuticals in Contract Manufacturing Operations (pdf)

Contained Chemistry – synthesizing highly potent compounds is a lucrative and growing niche for custom chemical manufacturers (pdf)

Handling Highly Potent Active Pharmaceutical Ingredients – Equipment Containment Performance (pdf)

Important Elements in Evaluating contract Manufacturing Organizations (pdf)

History, Implementation and Evolution of the Pharmaceutical Hazard Categorization and Control Systems (pdf)

Occupational Health Categorization and Compound Handling Practice Systems - Roots, Applications and Future (pdf)

Steps to Investigating Occupational Disease Incidents Involving “Potent Compound” Exposures (pdf)

Developing Occupational Exposure Limits (OELs) for Pharmaceutical Substances (pdf)

A Process Hazard Analysis Concept for Pharmaceutical Operations (pdf)

Industrial Hygiene Control Program Elements In Pharmaceutical Operations (pdf)

Approaches to Fate and Effects Testing of Active Pharmaceutical Ingredients (pdf)

Guidelines for Air Sampling Analytical Method Development Validation (pdf)

An Overview of Setting Occupational Exposure Limits (OELs) for Pharmaceuticals (pdf)

Manufacturing Highly Potent Drugs: Reducing the Risks (pdf)